Abstract P3-12-06: TOxicities of Locoregional Radiotherapy Associated with Bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation

MLA

PH Cottu, et al. “Abstract P3-12-06: TOxicities of Locoregional Radiotherapy Associated with Bevacizumab in Patients with Non-Metastatic Breast Cancer (TOLERAB): Final Long-Term Evaluation.” Cancer Research, vol. 79, Feb. 2019, pp. P3-12. EBSCOhost, https://doi.org/10.1158/1538-7445.sabcs18-p3-12-06.

APA

PH Cottu, C. Levy, A Gobillion, K Peignaux, B. De La Lande, A. Clément-Zhao, C. Lemanski, P. Bontemps, M-L Tanguy, A Reynaud-Bougnoux, Y.M. Kirova, & P Baumann. (2019). Abstract P3-12-06: TOxicities of Locoregional Radiotherapy Associated with Bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation. Cancer Research, 79, P3-12. https://doi.org/10.1158/1538-7445.sabcs18-p3-12-06

Chicago

PH Cottu, C. Levy, A Gobillion, K Peignaux, B. De La Lande, A. Clément-Zhao, C. Lemanski, et al. 2019. “Abstract P3-12-06: TOxicities of Locoregional Radiotherapy Associated with Bevacizumab in Patients with Non-Metastatic Breast Cancer (TOLERAB): Final Long-Term Evaluation.” Cancer Research 79 (February): P3-12. doi:10.1158/1538-7445.sabcs18-p3-12-06.